Skip Nav Destination
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies
Issue Archive
Table of Contents
STIMULUS REPORTS
Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells
Russell G. Witt,Emily M. Kreger,Laura B. Buckman,Patriss W. Moradi,Phong T. Ho,S. Christopher Derderian,Perry Tsai,Chris Baker,Nathaniel Schramm,Rachel Cleary,J. Victor Garcia,Tippi C. MacKenzie
HEMATOPOIESIS AND STEM CELLS
Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms
Judith C. W. Marsh,Fernanda Gutierrez-Rodrigues,James Cooper,Jie Jiang,Shreyans Gandhi,Sachiko Kajigaya,Xingmin Feng,Maria del Pilar F. Ibanez,Flávia S. Donaires,João P. Lopes da Silva,Zejuan Li,Soma Das,Maria Ibanez,Alexander E. Smith,Nicholas Lea,Steven Best,Robin Ireland,Austin G. Kulasekararaj,Donal P. McLornan,Anthony Pagliuca,Isabelle Callebaut,Neal S. Young,Rodrigo T. Calado,Danielle M. Townsley,Ghulam J Mufti
LYMPHOID NEOPLASIA
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
Clinical Trials & Observations
Maximilian Merz,Anna Jauch,Thomas Hielscher,Tilmann Bochtler,Stefan Olaf Schönland,Anja Seckinger,Dirk Hose,Uta Bertsch,Kai Neben,Marc Steffen Raab,Jens Hillengass,Hans Salwender,Igor Wolfgang Blau,Hans-Walter Lindemann,Ingo G. H. Schmidt-Wolf,Christof Scheid,Mathias Haenel,Katja C. Weisel,Hartmut Goldschmidt
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies
Clinical Trials & Observations
Brigitte T. A. van den Broek,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Kristin Page,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Annalisa Paviglianiti,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Janna Hol,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Heather Allewelt,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Fernanda Volt,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Gerard Michel,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Miguel Angel Diaz,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Victoria Bordon,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Tracey O'Brien,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Peter J. Shaw,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Chantal Kenzey,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Amal Al-Seraihy,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Peter M. van Hasselt,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Andrew R. Gennery,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Eliane Gluckman,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Vanderson Rocha,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Annalisa Ruggeri,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Joanne Kurtzberg,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,Jaap Jan Boelens,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center
ERRATUM
-
Cover Image
Cover Image
COVER FIGURE
Homology models of the proton-coupled folate transporter in the inward-open (blue) and outward-open (green) conformations. The 11th transmembrane domain and the Asn411 residue are highlighted. This residue is located within the external gate of the protein protruding into the aqueous channel and shifts further into the channel when the protein is in the inward-open conformation and the gate is closed. Mutation of Asn411 to Lys411 markedly impaired transport function, resulting in the autosomal recessive disorder hereditary folate malabsorption. See the article by Aluri et al. - PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals